Bionano Genomics (NASDAQ:BNGO) Stock Price Up 5.5% – Time to Buy?

Bionano Genomics, Inc. (NASDAQ:BNGOGet Free Report) shares were up 5.5% during mid-day trading on Wednesday . The company traded as high as $5.36 and last traded at $5.35. Approximately 165,486 shares were traded during trading, a decline of 52% from the average daily volume of 341,812 shares. The stock had previously closed at $5.07.

Wall Street Analysts Forecast Growth

Separately, LADENBURG THALM/SH SH cut Bionano Genomics from a “buy” rating to a “neutral” rating in a research note on Friday, November 15th.

View Our Latest Research Report on BNGO

Bionano Genomics Trading Up 1.3 %

The business’s fifty day moving average is $13.26 and its 200 day moving average is $21.55. The firm has a market capitalization of $600.38 million, a price-to-earnings ratio of -2.21 and a beta of 2.22. The company has a quick ratio of 0.99, a current ratio of 1.43 and a debt-to-equity ratio of 0.07.

Institutional Trading of Bionano Genomics

A number of institutional investors have recently made changes to their positions in BNGO. Carret Asset Management LLC increased its stake in Bionano Genomics by 89.0% in the 3rd quarter. Carret Asset Management LLC now owns 85,055 shares of the company’s stock valued at $39,000 after buying an additional 40,055 shares during the last quarter. GSA Capital Partners LLP acquired a new position in Bionano Genomics during the third quarter valued at approximately $46,000. Finally, Geode Capital Management LLC increased its position in shares of Bionano Genomics by 47.3% during the 3rd quarter. Geode Capital Management LLC now owns 882,854 shares of the company’s stock worth $401,000 after purchasing an additional 283,639 shares during the last quarter. Institutional investors own 11.35% of the company’s stock.

About Bionano Genomics

(Get Free Report)

Bionano Genomics, Inc provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight DNA.

Featured Articles

Receive News & Ratings for Bionano Genomics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bionano Genomics and related companies with MarketBeat.com's FREE daily email newsletter.